Lisa Barrett

1.3k total citations
21 papers, 240 citations indexed

About

Lisa Barrett is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Lisa Barrett has authored 21 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Infectious Diseases and 10 papers in Hepatology. Recurrent topics in Lisa Barrett's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Lisa Barrett is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Lisa Barrett collaborates with scholars based in Canada, United States and Israel. Lisa Barrett's co-authors include Glenn Patriquin, Todd F. Hatchette, Jason J. LeBlanc, Curtis Cooper, Marina B. Klein, Jordan J. Feld, Frances Tse, Matthew Carroll, Jason Grebely and Mel Krajden and has published in prestigious journals such as Gastroenterology, PLoS ONE and BMC Public Health.

In The Last Decade

Lisa Barrett

19 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Barrett Canada 9 156 122 117 41 26 21 240
Shintaro Nagashima Japan 12 177 1.1× 171 1.4× 102 0.9× 9 0.2× 10 0.4× 34 300
Patrizia Caligiuri Italy 10 177 1.1× 131 1.1× 117 1.0× 5 0.1× 29 1.1× 20 299
Vincenzina Fazio Italy 12 170 1.1× 227 1.9× 97 0.8× 7 0.2× 4 0.2× 29 336
Ayelet Keren‐Naus Israel 7 145 0.9× 26 0.2× 178 1.5× 14 0.3× 9 0.3× 9 294
R. Hammond Australia 10 263 1.7× 216 1.8× 145 1.2× 9 0.2× 6 0.2× 20 383
Linda Dunford Ireland 10 232 1.5× 174 1.4× 144 1.2× 78 1.9× 4 0.2× 15 352
G. Caspari Germany 8 107 0.7× 80 0.7× 27 0.2× 9 0.2× 5 0.2× 24 216
Ruben C. Hoogeveen Netherlands 7 213 1.4× 164 1.3× 52 0.4× 11 0.3× 2 0.1× 8 333
Caroline Lefeuvre France 8 103 0.7× 22 0.2× 192 1.6× 8 0.2× 70 2.7× 28 317
Jelle Koopsen Netherlands 7 114 0.7× 113 0.9× 55 0.5× 2 0.0× 11 0.4× 11 178

Countries citing papers authored by Lisa Barrett

Since Specialization
Citations

This map shows the geographic impact of Lisa Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Barrett more than expected).

Fields of papers citing papers by Lisa Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Barrett. The network helps show where Lisa Barrett may publish in the future.

Co-authorship network of co-authors of Lisa Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Barrett. A scholar is included among the top collaborators of Lisa Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Barrett. Lisa Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCracken, Gregory R., Glenn Patriquin, Todd F. Hatchette, et al.. (2024). Taqman PACMAN: a simple molecular approach for positive rapid antigen test confirmation during periods of low prevalence. Microbiology Spectrum. 12(5). e0407323–e0407323.
2.
Grant, Jennifer, John S. Lam, Sylvain Lother, et al.. (2023). AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 8(4). 245–252.
4.
Patriquin, Glenn, Jason J. LeBlanc, Todd F. Hatchette, et al.. (2022). Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer. Microbiology Spectrum. 10(1). e0245521–e0245521. 18 indexed citations
5.
Ramji, Alnoor, Karen Doucette, Curtis Cooper, et al.. (2022). Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue. World Journal of Gastroenterology. 28(31). 4390–4398. 4 indexed citations
6.
LeBlanc, Jason J., Gregory R. McCracken, Todd F. Hatchette, et al.. (2022). Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer. Microbiology Spectrum. 10(4). e0063922–e0063922. 5 indexed citations
7.
LeBlanc, Jason J., et al.. (2022). Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests. Microbiology Spectrum. 10(4). e0021722–e0021722. 30 indexed citations
8.
Jones, Jennifer, Frances Tse, Matthew Carroll, et al.. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Gastroenterology. 161(2). 681–700. 19 indexed citations
9.
Benchimol, Eric I., Frances Tse, Matthew Carroll, et al.. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines. Gastroenterology. 161(2). 669–680.e0. 15 indexed citations
10.
Vachon, Marie-Louise, Alexander Wong, Brian Conway, et al.. (2021). Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis. PubMed. 4(3). 283–291. 3 indexed citations
11.
Jones, Jennifer, Frances Tse, Matthew Carroll, et al.. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Journal of the Canadian Association of Gastroenterology. 4(4). e72–e91. 11 indexed citations
12.
Cooper, Curtis, David Wong, Sarah Haylock‐Jacobs, et al.. (2020). Distinct Hepatitis B and HIV co‐infected populations in Canada. Journal of Viral Hepatitis. 28(3). 517–527. 1 indexed citations
13.
Cooper, Curtis, Daniel Read, Marie-Louise Vachon, et al.. (2020). Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants. BMC Public Health. 20(1). 1345–1345. 7 indexed citations
14.
Benchimol, Eric I., Frances Tse, Matthew Carroll, et al.. (2020). 124 CANADIAN ASSOCIATION OF GASTROENTEROLOGY CLINICAL PRACTICE GUIDELINES ON IMMUNIZATIONS IN INFLAMMATORY BOWEL DISEASE. Gastroenterology. 158(6). S–23. 1 indexed citations
15.
German, Greg J., et al.. (2018). Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island. Annals of Hepatology. 17(2). 223–231. 6 indexed citations
16.
German, Greg J., et al.. (2017). Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island. Annals of Hepatology. 16(5). 749–758. 8 indexed citations
17.
Marshall, Alison D., Sahar Saeed, Lisa Barrett, et al.. (2016). Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ Open. 4(4). E605–E614. 61 indexed citations
18.
Hull, Mark, Stephen D. Shafran, Alex Wong, et al.. (2016). CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Canadian Journal of Infectious Diseases and Medical Microbiology. 2016. 1–34. 24 indexed citations
19.
Smyth, Daniel, et al.. (2014). Transitioning to Highly Effective Therapies for the Treatment of Chronic Hepatitis C Virus Infection: A Policy Statement and Implementation Guideline. Canadian Journal of Gastroenterology and Hepatology. 28(10). 529–534. 4 indexed citations
20.
Cortez, Karoll J., Michael A. Proschan, Lisa Barrett, et al.. (2013). Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients with or without HIV Infection. HIV Clinical Trials. 14(4). 149–159. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026